Editor: Shazia Anjum

Frontiers in Clinical Drug Research – Diabetes and Obesity

Volume 7

eBook: US $79 Special Offer (PDF + Printed Copy): US $124
Printed Copy: US $85
Library License: US $316
ISSN: 2467-9607 (Print)
ISSN: 2352-3220 (Online)
ISBN: 978-981-5123-59-3 (Print)
ISBN: 978-981-5123-58-6 (Online)
Year of Publication: 2023
DOI: 10.2174/97898151235861230701


Frontiers in Clinical Drug Research – Diabetes and Obesity is a book series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of two metabolic diseases – diabetes and obesity. The scope of the series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs affecting endocrine and metabolic processes linked with diabetes and obesity. Reviews in this series also include research on specific receptor targets and pre-clinical / clinical findings on novel pharmaceutical agents. Frontiers in Clinical Drug Research – Diabetes and Obesity is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of diabetes and obesity research.

The seventh volume of this series features 6 reviews on diabetes related topics for both medical specialists and pharmacologists.

- Clinical and diagnostic implications of glycated albumin in diabetes mellitus.

- Development of novel therapeutic groups and bioactive compounds from herbs for diabetes management

- Aspartame as a sugar substitute

- Mental health, adherence, and self-management among children with diabetes

- Cardioprotective effects of new generation anti-diabetic and lipid-lowering agents

- Epidemiology, pathophysiology, and treatment of diabesity


Medical specialists (endocrinology, diabetology, nutrition), pharmacologists and clinical researchers

WITHDRAWN: Partial Remission (honeymoon phase) in Type 1 Diabetes Mellitus

- Pp. 1
Sasigarn A. Bowden
View Abstract


- Pp. i
Shazia Anjum
Download Free

List of Contributors

- Pp. ii-iii (2)

Download Free

Clinical and Diagnostic Implications of Glycated Albumin in Diabetes Mellitus: An Update

- Pp. 1-21 (21)
Km Neelofar*, Jamshed Haneef, Farah Khan
View Abstract

Current Strategies of New Drugs for Diabetes Management

- Pp. 22-47 (26)
Maliha Sarfraz*, Rahman M. Hafizur, Hayat Ullah*, Sanaullah Sajid, Rana Waseem Akhtar, Mamoona Noreen, Shazia Perveen, Misbah Ullah Khan
View Abstract

Diabetes Type II: Should Aspartame be a Concern?

- Pp. 48-58 (11)
Arbind Kumar Choudhary*
View Abstract

Mental Health, Adherence, and Self-Management Among Children with Diabetes

- Pp. 59-116 (58)
Beáta Erika Nagy, Brigitta Munkácsi, Karolina Eszter Kovács*
View Abstract

Recent Trials on the Cardioprotective Effects of New Generation Anti-diabetic and Lipid-Lowering Agents

- Pp. 117-167 (51)
Omar M. Abdelfattah, Ahmed Sayed, Anas Al-Refaei, Jasmin Abdeldayem, Khaled Moustafa, Nicholas Elias, Yehia Saleh*
View Abstract

Diabesity and the Kidney

- Pp. 168-207 (40)
Mohamed E. Elrggal, Ahmed Elkeraie, Sol Carriazo, Hany Sawaf, Si Yuan Khor, Yasmine Elkeraie, Issa Haddad, Khaled Moustafa, Mohamed Hassanein*
View Abstract

Subject Index

- Pp. 208-215 (8)
Shazia Anjum
Download Free